BioPharma Dive ١٥ ديسمبر ٢٠٢٥ Kyverna to seek first clearance of a CAR-T therapy for autoimmune disease
BioPharma Dive ١٥ ديسمبر ٢٠٢٥ How rare-disease teams can fine-tune COAs to bridge meaningful change and measurable progress
BioPharma Dive ١٢ ديسمبر ٢٠٢٥ Arcus cancels work on Gilead-partnered cancer combo after trial setback
BioPharma Dive ١١ ديسمبر ٢٠٢٥ Biotech venture firm Apple Tree goes bankrupt amid dispute with billionaire backer
BioPharma Dive ١٠ ديسمبر ٢٠٢٥ A former Roivant spinout bets on AI-designed drugs for immune conditions